Australia, Nov. 5 -- Eyconis Inc., owns the trademark (2686202) for 'EYCONIS' till June 5, 2036.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment and alleviation of eye diseases and conditions; pharmaceutical preparations for the treatment and alleviation macular degeneration, diabetic macular edema, retinal vein occlusion, and geographic atrophy; medicines for use in ophthalmology treatments.] and 42 [Medical research; medical research in the fields of ophthalmology, eye disease, and eye conditions; medical research in the field of pharmaceutical preparations for the treatment and alleviation of eye disease and conditions; medical research in the field of pharmaceutical preparations for the treatment and alleviation macular degeneration, diabetic macular edema, retinal vein occlusion, and geographic atrophy; pharmaceutical drug development; pharmaceutical drug development in the fields of ophthalmology and eye disease; pharmaceutical drug development in the field of pharmaceutical preparations for the treatment and alleviation macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO) and geographic atrophy (GA); research and development of new products for medicinal use for others.]
Type of Mark: Word
Date of Acceptance: Aug. 28
Registration Advertised: Nov. 4
For further details contact Connie L. Ellerbach Fenwick & West LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2686202.
Disclaimer: Curated by HT Syndication.
